Our development path

Nothing good comes easy, it has been a steep learning curve to develop our product. The first version - based on published laboratory results(1,2) got positive consumer feedback but when evaluated in a clinical trial(3) a more simple version of the product worked just as well. Recent developments have opened an exciting new angle. We look forward to revealing the final product.

  1. Gomes et al, (2022) theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions. Front. Pharmacol. 12:752787
  2. Suzuki and Hara, (2009), Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J. Nutr., vol. 139, no. 5, pp. 965–974.
  3. Kuipers et al, (2023) The clinical effect of benescoTM on reflux symptoms: A double-blind randomized placebo-controlled trial, Neurogastroenterol Motil, p. e14648.